Rishav Adhikari (@rishavradhikari) 's Twitter Profile
Rishav Adhikari

@rishavradhikari

IM resident @StanfordMedicine | MD grad @HopkinsMedicine

ID: 1316933428475011073

calendar_today16-10-2020 02:46:19

4 Tweet

62 Followers

78 Following

JAHA (@jaha_aha) 's Twitter Profile Photo
JAHA
@jaha_aha

4 years ago

Despite the cardiovascular benefits of SGLT2is and GLP‐1RAs, these therapies have not reached the majority of patients for whom they are guideline recommended. Rishav Adhikari Michael J. Blaha #AHAJournals ahajournals.org/doi/10.1161/JA…

Despite the cardiovascular benefits of SGLT2is and GLP‐1RAs, these therapies have not reached the majority of patients for whom they are guideline recommended. <a href="/RishavRAdhikari/">Rishav Adhikari</a> <a href="/MichaelJBlaha/">Michael J. Blaha</a> #AHAJournals ahajournals.org/doi/10.1161/JA…
Kunal Jha (@kunaljhamd) 's Twitter Profile Photo
Kunal Jha
@kunaljhamd

3 years ago

Delighted to share our new review article “Transitioning to GLP-1 RAs and SGLT2 Inhibitors as the First Choice for Managing Cardiometabolic Risk in Type 2 Diabetes” rdcu.be/c0ncw Thank you Michael J. Blaha for your mentorship! We highlight some key figures & tables.

Rishav Adhikari (@rishavradhikari) 's Twitter Profile Photo
Rishav Adhikari
@rishavradhikari

3 years ago

Incredibly excited to match StanfordMedRes! Thank you to my family and the wonderful mentors I've had throughout my education for making this day possible: Susan Gurley, Matthew Sparks, MD, Francis Alenghat, Michael J. Blaha. Thrilled to be joining the amazing program at Stanford!

Incredibly excited to match <a href="/StanfordMedRes/">StanfordMedRes</a>! Thank you to my family and the wonderful mentors I've had throughout my education for making this day possible: Susan Gurley, <a href="/Nephro_Sparks/">Matthew Sparks, MD</a>, <a href="/alenghat/">Francis Alenghat</a>, <a href="/MichaelJBlaha/">Michael J. Blaha</a>. Thrilled to be joining the amazing program at Stanford!